BioRegenx 

BioRegenx, Inc. is an enterprise focused on the development, production, and distribution of both medical diagnostic equipment and scientifically formulated nutritional products, serving markets across the United States and internationally. Their diverse product lineup includes Endocalyx Pro, a dietary supplement specifically engineered to promote microvascular capillary health, along with a selection of other nutritional aids available under the MyBodyRx brand. The firm also provides GlycoCheck software and a variety of health and wellness technologies, such as pulsed electro-magnetic field devices, as well as the StimaWELL and ReLounge electronic muscle stimulation (EMS) therapy systems. Additionally, BioRegenx markets hydrogen water products. The company is also actively engaged in software development, having created the TruScan.Ai mobile application and website, which integrates various health indicators, and the VitalWellness app, designed to merge its DNA and epigenetics platform. Beyond physical and digital products, BioRegenx manages a social media content management platform that incorporates an interactive search engine. A significant offering is the DocSun Artificial Intelligence (AI) Engine. This advanced system leverages ballistocardiography for non-contact heartbeat detection and photoplethysmography, a light-based method for tracking blood flow. BioRegenx also distributes a range of general wellness devices. The company distributes its offerings directly to healthcare professionals and research organizations. BioRegenx, Inc.'s primary corporate office is situated in Chattanooga, Tennessee.